Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 25/2/2021
SIETES contiene 93212 citas

 
 
 1 a 20 de 23 siguiente >>
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas
Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, Demets D, Evans S, Law M, McMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercok P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 2016;388:2532-61. [Ref.ID 100988]
2.Enlace a cita originalTiene citas relacionadas
Baigent C. Aspirin for disease prevention: public policy or personal choice?. Ann Intern Med 2016;164:846-7. [Ref.ID 100467]
3. Cita con resumen
Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, Brott T, Cohen G, Davis S, Donnan G, Grotta J, Howard G, Kaste M, Koga M, von Kummer R, Lansberg M, Lindley RI, Murray G, Olivot JM, Parsons M, Tilley B, Toni D, Toyoda K, Wahlgren N, Wardlaw J, Whiteley W, del Zoppo GJ, Baigent C, Sandercock P, Hacke W, for the Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014;384:1929-35. [Ref.ID 98367]
4. Cita con resumen
Devereaux PJ, Mrkobrada M, Sessler DI, Leslie K, Epi M, Alonso-Coello P, Kurz A, Villar JC, Sigamani A, Biccard BM, Meyhoff ChS, Parlow JL, Guyatt G, Robinson A, Garg AX, Rodseth RN, Botto F, Lurati Buse G, Xavier D, Chan MTV, Tiboni M, Cook D, Kumar PA, Forget P, Malaga G, Fleischmann E, Amir M, Eikelboom J, Mizera R, Torres D, Wang CY, VanHelder T, Paniagua P, Berwanger O, Srinathan S, Graham M, Pasin L, Le Manach Y, Pogue J, Gao P, Whitlock R, Lamy A, Kearon C, Baigent C, Chow C, Pettit S, Chrolavicius S, Yusuf S, for the POISE-2 investigators. Aspirin in patients undergoing noncardiac surgery. N Engl J Med 2014;370:1494-503. [Ref.ID 97484]
5.
Reith C, Landray M, Devereaux PJ, Bosch J, Granger CB, Baigent C, Califf RM, Collins R, Yusuf S. Randomized clinical trials - Removing unnecessary obstacles. N Engl J Med 2013;369:1061-5. [Ref.ID 96099]
6.Tiene citas relacionadas Cita con resumen
Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet 2011;377:2181-92. [Ref.ID 91346]
7.Tiene citas relacionadas
Baigent C, Blackwell L, Emberson J, Collins R, Peto R, on behalf of the Antithrombotic Trialists' Collaboration. Aspirin in the primary prevention of vascular disease. ATT secretariat's reply. Lancet 2009;374:879. [Ref.ID 86689]
8.Tiene citas relacionadas Cita con resumen
Baigent C, Patrono C. Selective COX-2 inhibitors: where do we go from here?. Lancet 2008;372:1712-3. [Ref.ID 84518]
9.Tiene citas relacionadas Cita con resumen
Peto R, Emberson J, Landray M, Baigent C, Collins R, Clare R, Califf R. Analyses of cancer data from three ezetimibe trials. N Engl J Med 2008;359:1357-66. [Ref.ID 84067]
10.Tiene citas relacionadas
Kearney PM, Keech A, Simes J, Collins R, Baigent C, on behalf of the Cholesterol Treatment Trialists' (CTT) Collaboration. Statins and diabetes. Authors' reply. Lancet 2008;371:1752. [Ref.ID 82975]
11.Tiene citas relacionadas
13.Tiene citas relacionadas Cita con resumen
Baigent C, Keech A, Kearney P, Collins R, Simes J, on behalf of the Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of cholesterol-lowering treatment. Authors' reply. Lancet 2006;367:470-1. [Ref.ID 76163]
14.
Patrono C, García Rodríguez LA, Landolfi R, Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 2005;353:2373-83. [Ref.ID 75584]
15.Tiene citas relacionadas Cita con resumen
Baigent C. Aspirin for everyone older than 50? Against. BMJ 2005;330:1442-3. [Ref.ID 74185]
16.
Baigent C, Burbury K, Wheeler D. Premature cardiovascular disease in chronic renal failure. Lancet 2000;356:147-52. [Ref.ID 51745]
17. Cita con resumen
Baigent C, Chen Z, Collins R, Peto R, Sudow C. Immediate aspirin for suspected ischaemic stroke. Lancet 1999;353:151-2. [Ref.ID 42486]
18.
Peto R, Baigent C. Trials: the next 50 years. BMJ 1998;317:1170-1. [Ref.ID 41605]
19. Cita con resumen
Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R, on behalf of the ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. ISIS-2: 10 years survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. BMJ 1998;316:1337-43. [Ref.ID 39540]
20.
Collins R, Peto R, Baigent C, Sleight P. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med 1997;336:847-60. [Ref.ID 32581]
Seleccionar todas
 
 1 a 20 de 23 siguiente >>